A detailed history of California State Teachers Retirement System transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, California State Teachers Retirement System holds 3,490,731 shares of BMY stock, worth $202 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,490,731
Previous 3,484,483 0.18%
Holding current value
$202 Million
Previous $145 Million 24.83%
% of portfolio
0.21%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $247,795 - $323,334
6,248 Added 0.18%
3,490,731 $181 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $2.01 Million - $2.65 Million
49,970 Added 1.45%
3,484,483 $145 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $645,139 - $731,462
-13,446 Reduced 0.39%
3,434,513 $186 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $2.93 Million - $3.5 Million
60,431 Added 1.78%
3,447,959 $177 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $6.92 Million - $7.74 Million
-119,559 Reduced 3.41%
3,387,528 $197 Million
Q2 2023

Aug 21, 2023

SELL
$63.71 - $70.74 $14.5 Million - $16.1 Million
-227,574 Reduced 6.09%
3,507,087 $224 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $2.93 Million - $3.32 Million
-44,565 Reduced 1.18%
3,734,661 $259 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $4.39 Million - $5.2 Million
64,074 Added 1.72%
3,779,226 $272 Million
Q3 2022

Nov 18, 2022

SELL
$0.13 - $76.84 $10,546 - $6.23 Million
-81,126 Reduced 2.14%
3,715,152 $264 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $4.97 Million - $5.47 Million
-68,375 Reduced 1.77%
3,796,278 $292 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $15.4 Million - $18.5 Million
-250,663 Reduced 6.09%
3,864,653 $282 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $7.25 Million - $8.45 Million
135,189 Added 3.4%
4,115,316 $257 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $2.48 Million - $2.91 Million
41,954 Added 1.07%
3,980,127 $236 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $25.5 Million - $27.8 Million
-411,774 Reduced 9.47%
3,938,173 $263 Million
Q1 2021

May 18, 2021

SELL
$59.34 - $66.74 $2.08 Million - $2.34 Million
-35,118 Reduced 0.8%
4,349,947 $275 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.6 Million - $1.82 Million
27,783 Added 0.64%
4,385,065 $272 Million
Q3 2020

Nov 17, 2020

SELL
$57.43 - $63.64 $6.96 Million - $7.71 Million
-121,156 Reduced 2.71%
4,357,282 $263 Million
Q2 2020

Aug 17, 2020

BUY
$54.82 - $64.09 $1.19 Million - $1.39 Million
21,620 Added 0.49%
4,478,438 $263 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $1.32 Million - $1.92 Million
28,425 Added 0.64%
4,456,818 $248 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $78.7 Million - $103 Million
1,599,139 Added 56.52%
4,428,393 $284 Million
Q3 2019

Nov 15, 2019

SELL
$42.77 - $50.71 $2.92 Million - $3.46 Million
-68,320 Reduced 2.36%
2,829,254 $143 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $682,418 - $754,605
15,294 Added 0.53%
2,897,574 $131 Million
Q1 2019

May 09, 2019

BUY
$45.12 - $53.8 $6.11 Million - $7.28 Million
135,397 Added 4.93%
2,882,280 $138 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $1.35 Million - $1.75 Million
27,755 Added 1.02%
2,746,883 $143 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $71,636 - $80,800
1,298 Added 0.05%
2,719,128 $169 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $9.16 Million - $11.4 Million
-181,375 Reduced 6.26%
2,717,830 $150 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $5.36 Million - $6.17 Million
-89,427 Reduced 2.99%
2,899,205 $183 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $8.87 Million - $9.67 Million
147,920 Added 5.21%
2,988,632 $183 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $157 Million - $181 Million
2,840,712
2,840,712 $181 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.